Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity Against Mammarenaviruses In Vitro
October 21, 2021Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof, Juan C. de la TorreVirusesPublished: July 29,…Vidofludimus Calcium, a Next Generation DHODH Inhibitor for the Treatment of Relapsing-Remitting Multiple Sclerosis
October 21, 2021Andreas Muehler, Evelyn Peelen, Hella Kohlhof, Manfred Gröppel, Daniel VittMultiple Sclerosis and Related DisordersPublished: May 6, 2020https://doi.org/10.1016/j.msard.2020.102129Safety, Tolerability and Pharmacokinetics of Vidofludimus Calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects
October 21, 2021Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel VittEuropean Journal of Drug Metabolism and PharmacokineticsPublished: May 2, 2020https://doi.org/10.1007/s13318-020-00623-7The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study
October 21, 2021Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel VittDrugs in R&DPublished: October 16, 2019https://doi.org/10.1007/s40268-019-00286-z